What is Konnis?
Konnis operates as a critical player in the precision lab automation landscape, providing high-performance solutions that bridge the gap between complex robotic systems and laboratory efficiency. Since its inception in 2006, the company has carved out a niche by offering USA-made custom components, refurbished Tecan instrumentation, and comprehensive maintenance services. By focusing on the interoperability of liquid handling systems and the provision of high-quality consumables, Konnis enables research facilities to optimize their workflows while maintaining cost-effectiveness. Their independent status allows for a flexible, client-centric approach to automation, ensuring that laboratories can leverage advanced technology without being tethered to proprietary ecosystem constraints.
How much funding has Konnis raised?
Konnis has raised a total of $263K across 1 funding round:
Debt
$263K
Debt (2024): $263K with participation from St. Mary's Bank
Key Investors in Konnis
St. Mary's Bank
A financial institution providing commercial banking and debt financing solutions to support the operational growth of established enterprises.
What's next for Konnis?
With this late-stage financing, Konnis is poised to transition into a phase of aggressive scaling and technological refinement. The strategic allocation of these funds will likely prioritize the expansion of their custom manufacturing capacity and the enhancement of their service infrastructure to meet the growing demand for reliable, high-throughput laboratory automation. As the life sciences industry continues to prioritize efficiency and data reproducibility, Konnis is strategically aligned to capture additional market share. Future growth initiatives will likely focus on deepening their technical expertise in robotic integration and broadening their portfolio of compatible components, further cementing their role as an essential partner for modern research institutions and diagnostic laboratories worldwide.
See full Konnis company page
